» Articles » PMID: 18360024

Current Status and Characteristics of Hypertension Control in Community Resident Elderly Korean People: Data from a Korean Longitudinal Study on Health and Aging (KLoSHa Study)

Overview
Journal Hypertens Res
Date 2008 Mar 25
PMID 18360024
Citations 13
Authors
Affiliations
Soon will be listed here.
Abstract

Hypertension is a common disease that greatly impacts the health of the elderly. However, the status of blood pressure (BP) control in the elderly Korean population has not yet been investigated. Subjects aged 65 years or older living in Seongnam city, a suburb of Seoul, Korea, were included in this study. All subjects were evaluated by a physician, and medication was reviewed by a nurse. Seated BPs were measured by a trained nurse using standard methods. A total of 995 subjects were included in the current analysis (mean age: 76.3+/-8.7 years). The prevalence of hypertension was 68.7% in the study population, and this value increased with age, peaked in the 75-84 age group, and decreased thereafter. Only 66.1% of hypertensive patients had taken any antihypertensive medication, among which calcium channel blockers (64.2%) were most commonly used. Among the patients on antihypertensive medication, 46% were on combination drug therapy. BP was controlled in 38.5% of hypertensive patients, with systolic BP less controlled than diastolic BP, especially in the oldest-old population. The BP control rate was lower in high-risk patients of diabetes and renal disease. In conclusion, in community resident elderly populations, the BP control rate remains unsatisfactory, especially in high-risk patients. The benefit and optimal level of BP control in oldest-old population must be investigated because a lot of elderly hypertensive patients are currently being managed without definite evidence of related benefits.

Citing Articles

Sex Differences in the Heterogeneous Dynamic Incidence of Oral Cancer: A Comparison between Taiwan and Thailand.

Siewchaisakul P, Sarakarn P, Vatanasapt P, Chen S, Yen A Biomed Res Int. 2020; 2020:9321246.

PMID: 33015186 PMC: 7512095. DOI: 10.1155/2020/9321246.


Prevalence, Treatment, Control and Monitoring of Hypertension: A Nationwide Community-Based Survey in Taiwan, 2017.

Pan H, Lin H, Chen W, Wang T Acta Cardiol Sin. 2020; 36(4):375-381.

PMID: 32675930 PMC: 7355114. DOI: 10.6515/ACS.202007_36(4).20191220A.


Systematic Review with Network Meta-Analysis: Comparative Efficacy and Safety of Combination Therapy with Angiotensin II Receptor Blockers and Amlodipine in Asian Hypertensive Patients.

Lee D, Jung M, Wang H, Khan Z, Pinton P Int J Hypertens. 2019; 2019:9516279.

PMID: 31827918 PMC: 6885253. DOI: 10.1155/2019/9516279.


S-amlodipine plus chlorthalidone vs. S-amlodipine plus telmisartan in hypertensive patients unresponsive to amlodipine monotherapy: study protocol for a randomized controlled trial.

Jo S, Park S, Kim E, Kim S, Cho H, Song J Trials. 2018; 19(1):324.

PMID: 29925421 PMC: 6011241. DOI: 10.1186/s13063-018-2636-1.


Utilization of Osteoporosis-Related Health Services: Use of Data from the Korean National Health Insurance Database 2008-2012.

Yu T, Cho H, Kim T, Ha Y, Jang S, Kim H J Korean Med Sci. 2017; 33(3):e20.

PMID: 29215807 PMC: 5729648. DOI: 10.3346/jkms.2018.33.e20.